Context Therapeutics Inc. · NASDAQ:CNTX
Opaleye Management Inc. reported a 0% stake in Context Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Opaleye Management Inc. reported a 0% stake in Context Therapeutics Inc., 0 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Opaleye Management Inc. | 0% | 0 |
Source
Related
- Context Therapeutics Inc.
- Opaleye Management Inc.
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026